Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies.
Wang N, Hu X, Cao W, Li C, Xiao Y, Cao Y, Gu C, Zhang S, Chen L, Cheng J, Wang G, Zhou X, Zheng M, Mao X, Jiang L, Wang D, Wang Q, Lou Y, Cai H, Yan D, Zhang Y, Zhang T, Zhou J, Huang L. Wang N, et al. Among authors: cai h. Blood. 2020 Jan 2;135(1):17-27. doi: 10.1182/blood.2019000017. Blood. 2020. PMID: 31697824 Free article. Clinical Trial.
A novel full-human CD22-CAR T cell therapy with potent activity against CD22low B-ALL.
Tan Y, Cai H, Li C, Deng B, Song W, Ling Z, Hu G, Yang Y, Niu P, Meng G, Cheng W, Xu J, Duan J, Wang Z, Yu X, Feng X, Zhou J, Pan J. Tan Y, et al. Among authors: cai h. Blood Cancer J. 2021 Apr 10;11(4):71. doi: 10.1038/s41408-021-00465-9. Blood Cancer J. 2021. PMID: 33839735 Free PMC article. Clinical Trial. No abstract available.
8,210 results